| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D D Cung, G L Stimme. Reemergence of positive symptoms after initial response to risperidone. Pharmacotherapy. vol 17. issue 2. 1997-05-27. PMID:9085334. |
risperidone was effective in successfully treating a patient's negative symptoms of schizophrenia as well as reducing adverse effects from typical antipsychotic drugs. |
1997-05-27 |
2023-08-12 |
Not clear |
| D D Cung, G L Stimme. Reemergence of positive symptoms after initial response to risperidone. Pharmacotherapy. vol 17. issue 2. 1997-05-27. PMID:9085334. |
reemergence of psychotic symptoms after initial response might be explained by inadequate dosage, by the natural course of the patient's schizophrenia independent of drug therapy, or by the possibility that, for this patient, risperidone was less effective than chlorpromazine for the positive symptom of auditory hallucinations. |
1997-05-27 |
2023-08-12 |
Not clear |
| J A Matte. Risperidone: how good is the evidence for efficacy? Schizophrenia bulletin. vol 23. issue 1. 1997-05-21. PMID:9050121. |
it is as yet unclear whether risperidone is as effective as standard neuroleptics for positive schizophrenia symptoms in neuroleptic-responsive patients. |
1997-05-21 |
2023-08-12 |
Not clear |
| A Rossi, F Mancini, P Stratta, P Mattei, R Gismondi, F Pozzi, M Casacchi. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study. Acta psychiatrica Scandinavica. vol 95. issue 1. 1997-05-20. PMID:9051159. |
risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study. |
1997-05-20 |
2023-08-12 |
Not clear |
| R C Smith, R P Kadewar. Neurological soft signs and response to risperidone in chronic schizophrenia. Biological psychiatry. vol 40. issue 10. 1997-05-13. PMID:8915566. |
neurological soft signs and response to risperidone in chronic schizophrenia. |
1997-05-13 |
2023-08-12 |
Not clear |
| D J Still, P G Dorson, M L Crismon, C Pousso. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone. Psychiatric services (Washington, D.C.). vol 47. issue 12. 1997-04-23. PMID:9117479. |
effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone. |
1997-04-23 |
2023-08-12 |
Not clear |
| D J Still, P G Dorson, M L Crismon, C Pousso. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone. Psychiatric services (Washington, D.C.). vol 47. issue 12. 1997-04-23. PMID:9117479. |
a prospective, open-label study in a 400-bed state psychiatric hospital evaluated change in therapeutic response among ten patients with treatment-resistant schizophrenia who were switched from clozapine to risperidone. |
1997-04-23 |
2023-08-12 |
Not clear |
| D J Still, P G Dorson, M L Crismon, C Pousso. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone. Psychiatric services (Washington, D.C.). vol 47. issue 12. 1997-04-23. PMID:9117479. |
the findings do not support replacing clozapine with risperidone for patients with treatment-resistant schizophrenia. |
1997-04-23 |
2023-08-12 |
Not clear |
| G E Davis, W E Lowell, G L Davi. Measuring quality of care in a psychiatric hospital using artificial neural networks. American journal of medical quality : the official journal of the American College of Medical Quality. vol 12. issue 1. 1997-04-18. PMID:9116530. |
the study took place during hospital downsizing (political change), a consent decree (policy change), new administrative and medical personnel (staffing change), and the introduction of clozapine and risperidone for schizophrenia (therapeutic change). |
1997-04-18 |
2023-08-12 |
Not clear |
| I R de Oliveira, A M Miranda-Scippa, E P de Sena, E L Pereira, M G Ribeiro, E de Castro-e-Silva, J Bacaltchu. Risperidone versus haloperidol in the treatment of schizophrenia: a meta-analysis comparing their efficacy and safety. Journal of clinical pharmacy and therapeutics. vol 21. issue 5. 1997-04-18. PMID:9119918. |
risperidone versus haloperidol in the treatment of schizophrenia: a meta-analysis comparing their efficacy and safety. |
1997-04-18 |
2023-08-12 |
Not clear |
| J K Patel, C Salzman, A I Green, M T Tsuan. Chronic schizophrenia: response to clozapine, risperidone, and paroxetine. The American journal of psychiatry. vol 154. issue 4. 1997-04-16. PMID:9090343. |
chronic schizophrenia: response to clozapine, risperidone, and paroxetine. |
1997-04-16 |
2023-08-12 |
Not clear |
| R C Millson, C E Emes, W G Glackma. Self-induced water intoxication treated with risperidone. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 41. issue 10. 1997-04-02. PMID:8978944. |
to determine whether or not risperidone is efficacious in treating self-induced water intoxication in patients with chronic schizophrenia. |
1997-04-02 |
2023-08-12 |
Not clear |
| L C Kopal. Spontaneous and drug-induced movement disorders in schizophrenia. Acta psychiatrica Scandinavica. Supplementum. vol 389. 1997-04-02. PMID:8985472. |
clinical trials have shown that risperidone is effective in first-episode schizophrenia. |
1997-04-02 |
2023-08-12 |
Not clear |
| E Stip, I Lussie. The effect of risperidone on cognition in patients with schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 41. issue 8 Suppl 2. 1997-03-18. PMID:8899249. |
the effect of risperidone on cognition in patients with schizophrenia. |
1997-03-18 |
2023-08-12 |
Not clear |
| V S Anand, M J Dewa. Withdrawal-emergent dyskinesia in a patient on risperidone undergoing dosage reduction. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 8. issue 3. 1997-03-14. PMID:8899136. |
a 23-year-old, white male with history of paranoid schizophrenia developed a withdrawal-emergent dyskinesia during a dose reduction of risperidone. |
1997-03-14 |
2023-08-12 |
Not clear |
| F Raleig. Use of novel antipsychotic drugs. Pharmacotherapy. vol 16. issue 6 Pt 2. 1997-03-04. PMID:8948000. |
the atypical antipsychotic agents clozapine and risperidone bring new insight into the care and treatment of patients with schizophrenia. |
1997-03-04 |
2023-08-12 |
Not clear |
| A Schotte, P F Janssen, W Gommeren, W H Luyten, P Van Gompel, A S Lesage, K De Loore, J E Leyse. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology. vol 124. issue 1-2. 1997-01-29. PMID:8935801. |
the predominant 5ht2a receptor occupancy probably plays a role in the beneficial action of risperidone on the negative symptoms of schizophrenia, whereas maintenance of a moderate occupancy of d2 receptors seems adequate for treating the positive symptoms of schizophrenia. |
1997-01-29 |
2023-08-12 |
human |
| W C Lykes, J E Cuev. Risperidone in children with schizophrenia -letter-. Journal of the American Academy of Child and Adolescent Psychiatry. vol 35. issue 4. 1997-01-21. PMID:8919701. |
risperidone in children with schizophrenia -letter-. |
1997-01-21 |
2023-08-12 |
Not clear |
| M Maes, E Bosmans, R Ranjan, E Vandoolaeghe, H Y Meltzer, M De Ley, R Berghmans, G Stans, R Desnyde. Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs. Schizophrenia research. vol 21. issue 1. 1997-01-21. PMID:8998275. |
cc16, and that the latter may constitute a trait market of schizophrenia; and that (ii) chronic treatment with atypical antipsychotic agents, i.e., risperidone, may normalize lower plasma cc16 and increase plasma sil-2r. |
1997-01-21 |
2023-08-12 |
Not clear |
| J J López Ibor, J L Ayuso, M Gutiérrez, J Guimon, M L Herraiz, A Chinchilla, J L Ayuso, A González Pinto, I Eguiluz, A Fernánde. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol]. Actas luso-espanolas de neurologia, psiquiatria y ciencias afines. vol 24. issue 4. 1997-01-03. PMID:8984849. |
[risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol]. |
1997-01-03 |
2023-08-12 |
Not clear |